before the procedure by an attending interventional radiologist. Injury to adjacent critical organs and potential maneuvers to mitigate such risks were specifically discussed in each case. All procedures were performed under general anesthesia administered by an attending anesthesiologist. All interventional procedures were performed by an attending interventional radiologist.
All procedures were performed in a single hybrid angiography suite using EPIQ ultrasound (Philips Medical), Artis Zee interventional angiography system (Siemens Medical), and SOMATOM Definition AS computed tomography (CT) (Siemens Medical). All ablations were formed with a microwave ablation system (HS Amica). Fibrillar collagen injection and percutaneous ablation were performed, in standard clinical fashion, based on operator preference. Targeted ultrasound of the liver was performed to identify the hepatic malignancy and determine a safe path for percutaneous placement of a 14-gauge × 15 cm microwave antenna. The antenna was placed centrally within each lesion under ultrasound-guid-
Main points
• Thermal ablation of hepatocellular cancer has proven to be highly effective, but can be challenging when adjacent to thermally sensitive structures. Several techniques have been described to decrease the potential for collateral thermal injury, though each has limitations.
• Fibrillar collagen has been used as a hemostatic agent and can be dissolved to form a consistent slurry that can be focally delivered. In this case series, fibrillar collagen was delivered and successfully created a barrier between the ablation zone and thermally sensitive tissue.
• Advantages of using fibrillar collagen to displace thermally sensitive tissue is the durability of displacement, the small volume that is needed, and the presence of collagen to facilitate hemostasis and healing. ance with subsequent CT confirmation. In all cases, adjacent critical organ collateral damage was inevitable and a protection strategy was undertaken. A 21-gauge × 15 cm Chiba needle was interposed between the liver and the adjacent critical organ. Over a 0.018-inch wire, the needle was exchanged for a 4 F dilator. Fibrillar collagen, dissolved in a solution of 9 mL normal saline and 1 mL of iodinated contrast (Isovue 300; Bracco Diagnostics), was loaded in a 10 mL syringe and subsequently injected in small aliquots to displace the at-risk organ. Intraprocedural CT imaging was performed to confirm that all at-risk organs were safely displaced from the prospective ablation zone. Injected volumes ranged from 10-30 mL. In each case, microwave ablation was performed using 40-60 watts for 12-15 minutes to cover the entire lesion with a margin of 5-10 mm. All patients were discharged within 24-hours and clinical evaluation in the interventional radiology clinic occurred within 2-weeks, which consisted of an interval history and physical examination with laboratory evaluation. No minor or major complications occurred. Three-month clinical follow-up included a clinic visit and interval imaging which showed completely ablated malignancy without collateral organ injury in all cases.
Patient #1:
A 65-year-old male, Eastern Cooperative Oncology Group (ECOG) 0 and Childs-Pugh (CP) Class A, with history of Hepatitis C cirrhosis and no prior locoregional therapy, developed a 2.6 cm HCC along the anteroinferior capsular margin of hepatic segment 5, abutting the gallbladder fundus and hepatic flexure of the colon (Fig. 2) .
Patient #2:
A 78-year-old female, ECOG 0 and CP Class A, with history of alcoholic cirrhosis and no prior locoregional therapy, developed a 1.9 cm HCC in the posteroinferior margin of hepatic segment 6, abutting the gallbladder body and hepatic flexure of the colon (Fig. 3) .
Patient #3:
A 66-year-old male, ECOG 1 and CP Class B, with a history of Hepatitis C cirrhosis and HCC previously underwent transarterial chemoembolization to 2 lesions and microwave ablation to 2 further lesions, developed a new 10 mm HCC in segment 3 abutting the stomach.
Discussion
Percutaneous tumor ablation is performed throughout the body to address malignancies with high success and low complication rates. However, despite refinements in ablation technology, a limitation in liver ablation is adjacent thermal injury when the target lesion is along the surface of the liver as demonstrated in these patients. Strategies have emerged to protect the surrounding tissues including fluid or gas displacement, balloon interposition, thermometry, and torqueing of tissue (4, 5) .
The most commonly employed strategies involve introduction of fluid or gas as a barrier, predominantly normal saline, 5% dextrose in water, or CO 2 gas. However, both fluid and gas have low viscosity, distribute freely throughout the abdomen, and may be absorbed by the peritoneum, decreasing the durability of separation. Not uncommonly, large volumes or continuous infusions are required, which may increase intra-abdominal pressure, may be problematic in patients susceptible to fluid overload, and may result in patient discomfort. Additionally, CO 2 gas may preclude the use of ultrasonography for lesional targeting or adjustment of probes. Studies have shown Panels (c-e) show a needle inserted just anterior to the liver mass in order to inject contrast-loaded fibrillar collagen and displace the colon away from the mass (arrow). There is a much wider interface between the mass (e, arrow) and the colon (e, arrowhead). Follow-up contrastenhanced MRI (f) of the mass after ablation (arrow) demonstrates complete devascularization of the mass without injury to adjacent structure. that the instillation of fluid separated the liver from the gastrointestinal tract in 78% of cases (4, 5) . Most recently, reports have emerged using a hyaluronic acid gel in humans and thermoprotective gels in an animal model (7, 8) . Fibrillar collagen is an absorbable bovine collagen hemostatic agent, which is available in fibrillar and pad forms. The fibrillar form dissolves in solution and is used as a hemostatic agent (6) . Dilution of fibrillar collagen in 10 mL of fluid creates a slurry, which is easily injected through a 3 F or 4 F dilator. In these cases, utilizing between 10 and 30 mL of fibrillar collagen slurry created 15-21 mm of durable separation between the liver and adjacent structures which persisted throughout the remainder of the ablation procedure without reapplication. Although the package insert for fibrillar collagen states that complete intraperitoneal absorption may not occur at 56 days, follow-up imaging at 8-12 weeks revealed resorption of the collagen in these 3 patients.
Fibrillar collagen appears well-tolerated, safe, and is of little cost. Moreover, it does not preclude other organ separation strategies. Limitations to this study include the sample size of 3 patients and that it was performed at a single institution without comparison to other separation agents.
In conclusion, strategies and techniques have been developed to protect tissues adjacent to ablation zones. Fibrillar collagen appears to be a safe and effective addition to the armamentarium. Fibrillar collagen may have advantages in that a small volume is necessary, the separation is durable, and the presence of collagen may facilitate hemostasis and healing. 
